OpenFilings

Protara Therapeutics, Inc.

Form10-Q

Report Period2026-06-30

Date Filed2026-08-11

Time Filed08:10:59

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

QUARTERLY REPORT
THIRD CERTIFICATE OF AMENDMENT TO THE SIXTH AMENDED AND RESTATED CERTIFICATE OF
COMPOSITE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPANY
AMENDMENT NO. 1 TO THE COMPANY'S 2024 EQUITY INCENTIVE PLAN, AS AMENDED
CERTIFICATION
CERTIFICATION
CERTIFICATION
Filing on SEC Edgar